Uncategorized

Farrell replaces Tom Frinzi on the heels of a challenging year for the eye implant maker marked by a demand slowdown in China, its largest market.

Mexico, Canada and China all announced they would counter the president’s orders after additional duties went into effect this week.

Experts at HIMSS say the adoption of futuristic artificial intelligence products doesn’t necessarily mean leaving smaller, cash-strapped providers behind.

Overall employment could fall by 286,000 jobs next year if the enhanced premium tax credits lapse, including 130,000 lost roles in the healthcare sector.

The president also maintained that the pause on duties for Canada and Mexico will come to an end Tuesday.

Mickelsen, whose work led to the development of Boston Scientific’s fast-growing Farapulse device, is building a new PFA tool for ventricular tachycardia as CEO of startup Field Medical.

President Donald Trump upped tariffs on China and said delayed tariffs on Mexico and Canada would take effect. Catch up on MedTech Dive’s latest coverage.

Less than two months after two FDA-related setbacks, Atara Biotherapeutics is again cutting its workforce in half. This time, it’s also hitting pause on two CAR T programs, including one affected by an FDA clinical hold in January.

The approval for the first-line treatment of esophageal squamous cell carcinoma comes shortly after a label expansion for the drug in gastric and gastroesophageal cancers as BeiGene also pushes forward a pipeline of novel cancer therapies.

The partners are pushing to expand Enhertu’s list of indications beyond its standing uses in breast, lung and gastric cancers.